CCM
PBYI icon

Cupps Capital Management’s Puma Biotechnology PBYI Stock Holding History

Cupps Capital Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-29,815
Closed -$7.04M – 207
2015
Q1 		$7.04M Buy
+29,815
New +$6.37M 0.63% 64
2014
Q2 		– Sell
-35,011
Closed -$3.65M – 231
2014
Q1 		$3.65M Buy
+35,011
New +$4.12M 0.28% 111

Other funds holding PBYI

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Cupps Capital Management's PBYI Position: Q2 2015 in Review

Cupps Capital Management sold out of Puma Biotechnology (PBYI) in Q2 2015, closing a stake of 29,815 shares — an estimated $7.04M sold.

Cupps Capital Management first reported a position in PBYI in Q1 2014 and held it in 2 quarters. The position peaked at $7.04M in Q1 2015. 198 funds tracked by Wall St. Rank hold PBYI as of Q2 2015.

  • Cupps Capital Management reported no remaining Puma Biotechnology position as of Q2 2015 after selling out during the quarter.
  • Cupps Capital Management sold 29,815 Puma Biotechnology shares in Q2 2015, an estimated $7.04M.
  • Cupps Capital Management first reported a position in Puma Biotechnology in Q1 2014 and held it in 2 quarters.
  • Cupps Capital Management's Puma Biotechnology position peaked at $7.04M in Q1 2015.
  • 198 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2015.

Based on Cupps Capital Management's 13F filing for Q2 2015, filed 6 Aug 2015.